StonvexLoading…
StonvexStonvexStonvexCore line items from MVST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $427.52M | $379.80M | $306.62M | $204.50M |
Operating Income | $6.98M | $-116.09M | $-106.73M | $-159.95M |
Net Income | $-29.22M | $-195.46M | $-106.34M | $-158.20M |
EPS (Diluted) | $-0.09 | $-0.61 | $-0.34 | $-0.52 |
Total Assets | $1.01B | $951.87M | $1.10B | $984.96M |
Total Liabilities | $594.93M | $563.97M | $532.54M | $371.98M |
Cash & Equivalents | $104.96M | $73.01M | $44.54M | $231.42M |
Free Cash Flow OCF − CapEx | $56.07M | $-24.91M | $-262.09M | $-204.81M |
Shares Outstanding | 331.79M | 323.14M | 315.01M | 307.63M |